Prothena Total Operating Expenses vs Net Income From Continuing Ops Analysis
PRTA Stock | USD 20.81 0.60 2.97% |
Prothena Plc financial indicator trend analysis is much more than just breaking down Prothena plc prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Prothena plc is a good investment. Please check the relationship between Prothena Plc Total Operating Expenses and its Net Income From Continuing Ops accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Prothena plc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For information on how to trade Prothena Stock refer to our How to Trade Prothena Stock guide.
Total Operating Expenses vs Net Income From Continuing Ops
Total Operating Expenses vs Net Income From Continuing Ops Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Prothena plc Total Operating Expenses account and Net Income From Continuing Ops. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between Prothena Plc's Total Operating Expenses and Net Income From Continuing Ops is -0.63. Overlapping area represents the amount of variation of Total Operating Expenses that can explain the historical movement of Net Income From Continuing Ops in the same time period over historical financial statements of Prothena plc, assuming nothing else is changed. The correlation between historical values of Prothena Plc's Total Operating Expenses and Net Income From Continuing Ops is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Operating Expenses of Prothena plc are associated (or correlated) with its Net Income From Continuing Ops. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Income From Continuing Ops has no effect on the direction of Total Operating Expenses i.e., Prothena Plc's Total Operating Expenses and Net Income From Continuing Ops go up and down completely randomly.
Correlation Coefficient | -0.63 |
Relationship Direction | Negative |
Relationship Strength | Weak |
Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Net Income From Continuing Ops
Most indicators from Prothena Plc's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Prothena plc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Prothena plc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For information on how to trade Prothena Stock refer to our How to Trade Prothena Stock guide.As of June 2, 2024, Selling General Administrative is expected to decline to about 34.6 M. The current year's Tax Provision is expected to grow to about (12.8 M)
2021 | 2022 | 2023 | 2024 (projected) | Total Operating Expenses | 128.6M | 185.5M | 282.4M | 296.5M | Cost Of Revenue | 82.3M | 6.7M | 8.4M | 8.0M |
Prothena Plc fundamental ratios Correlations
Click cells to compare fundamentals
Prothena Plc Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Prothena Plc fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Common Stock Shares Outstanding | 39.9M | 39.9M | 48.5M | 47.4M | 53.2M | 35.1M | |
Total Assets | 419.3M | 333.0M | 609.4M | 758.0M | 696.4M | 414.8M | |
Other Current Liab | 6.8M | 11.3M | 16.2M | 23.0M | (37.0M) | (35.2M) | |
Total Current Liabilities | 17.7M | 25.8M | 33.5M | 50.1M | 56.9M | 59.7M | |
Total Stockholder Equity | 272.9M | 184.0M | 466.0M | 622.0M | 561.4M | 325.8M | |
Accounts Payable | 1.2M | 4.1M | 3.7M | 9.3M | 25.4M | 26.7M | |
Other Assets | 13.7M | 31.1M | 10.4M | 30.9M | 35.6M | 37.3M | |
Total Liab | 146.3M | 149.0M | 143.3M | 136.0M | 135.0M | 89.0M | |
Property Plant Equipment | 3.9M | 2.6M | 2.0M | 8.0M | 9.2M | 16.9M | |
Property Plant And Equipment Net | 27.1M | 20.4M | 14.1M | 8.0M | 16.0M | 22.5M | |
Non Current Assets Total | 40.9M | 33.7M | 24.6M | 38.9M | 57.1M | 36.0M | |
Non Currrent Assets Other | 3.8M | 1.7M | 3.4M | 12.7M | 40.2M | 42.3M | |
Liabilities And Stockholders Equity | 419.3M | 333.0M | 609.4M | 758.0M | 696.4M | 446.4M | |
Non Current Liabilities Total | 128.6M | 123.1M | 109.9M | 85.8M | 78.1M | 67.8M | |
Other Current Assets | 2.7M | 2.5M | 5.7M | 8.7M | 19.1M | 20.1M | |
Other Stockholder Equity | 944.4M | 966.6M | 1.2B | 1.5B | 1.5B | 822.4M | |
Property Plant And Equipment Gross | 27.1M | 20.4M | 14.1M | 8.0M | 23.4M | 22.3M | |
Total Current Assets | 378.4M | 299.3M | 584.8M | 719.1M | 639.3M | 410.5M | |
Net Debt | (352.8M) | (277.5M) | (566.8M) | (703.9M) | (608.3M) | (577.9M) | |
Retained Earnings | (671.9M) | (783.0M) | (716.1M) | (833.0M) | (980.0M) | (931.0M) | |
Cash | 375.7M | 295.4M | 579.1M | 710.4M | 620.2M | 438.0M | |
Cash And Short Term Investments | 375.7M | 295.4M | 579.1M | 710.4M | 620.2M | 438.0M | |
Net Receivables | 68K | 15K | 13K | 62K | 5.2M | 5.4M | |
Net Tangible Assets | 272.9M | 184.0M | 466.0M | 622.0M | 715.3M | 381.1M | |
Retained Earnings Total Equity | (598.0M) | (671.9M) | (783.0M) | (716.1M) | (644.4M) | (676.7M) | |
Capital Surpluse | 920.6M | 944.4M | 966.6M | 1.2B | 1.4B | 801.6M | |
Deferred Long Term Liab | 254K | 110.4M | 110.2M | 102.9M | 118.4M | 124.3M | |
Short Term Debt | 5.1M | 5.5M | 5.9M | 6.5M | 1.1M | 1.1M | |
Non Current Liabilities Other | 18.4M | 12.9M | 6.9M | 553K | 497.7K | 472.8K | |
Short Long Term Debt Total | 22.9M | 17.8M | 12.3M | 6.5M | 11.8M | 22.7M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Prothena plc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Prothena Plc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Prothena Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Prothena Plc Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Prothena plc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For information on how to trade Prothena Stock refer to our How to Trade Prothena Stock guide.You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Complementary Tools for Prothena Stock analysis
When running Prothena Plc's price analysis, check to measure Prothena Plc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Prothena Plc is operating at the current time. Most of Prothena Plc's value examination focuses on studying past and present price action to predict the probability of Prothena Plc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Prothena Plc's price. Additionally, you may evaluate how the addition of Prothena Plc to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Stocks Directory Find actively traded stocks across global markets | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume |
Is Prothena Plc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Prothena Plc. If investors know Prothena will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Prothena Plc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.21) | Revenue Per Share 1.668 | Quarterly Revenue Growth (0.98) | Return On Assets (0.20) | Return On Equity (0.31) |
The market value of Prothena plc is measured differently than its book value, which is the value of Prothena that is recorded on the company's balance sheet. Investors also form their own opinion of Prothena Plc's value that differs from its market value or its book value, called intrinsic value, which is Prothena Plc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Prothena Plc's market value can be influenced by many factors that don't directly affect Prothena Plc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Prothena Plc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Prothena Plc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Prothena Plc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.